| book details |

Disease Control Priorities, Third Edition (Volume 3): Cancer

Edited by Hellen Gelband, Edited by Jha Prabhat, Edited by Rengaswamy Sankaranarayanan, Edited by Susan Horton

| on special |

normal price: R 1,659.95

Price: R 1,493.95

| add to trolley |

| book description |

Volume Â 3, Â Cancer, Â presents Â the Â complex Â patterns Â of Â cancer Â incidence Â and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation of cancer will indicate where cancer treatment Â is Â ineffective Â and Â wasteful, Â and Â offer Â alternative Â cancer Â care packages that are cost-effective and suited to low-resource settings. Main messages from the volume include: Quality matters in all aspects of cancer treatment and palliation. Cancer registries that track incidence, mortality, and survival, paired with systems to capture causes of death are important to understanding the national cancer burden and the effect of interventions over Â time. Effective Â interventions Â exist Â at Â a Â range Â of Â prices. Â Adopting â€œresource appropriate"" measures which allow the most effective treatment for Â the Â greatest Â number Â of Â people Â will Â be Â advantageous to countries. Prioritizing resources toward early stage and curable cancers is likely to have the greatest health impact in low income settings. Research prioritization is no longer just a global responsibility.Providing cancer treatment requires adequate Â numbers Â of Â trained healthcare Â professionals Â and Â infrastructure beyond Â what Â is Â available Â in Â most Â LMICs, Â especially Â low Â income Â countries. Careful patient monitoring is a requirement of good quality cancer care and this often involves laboratory tests in addition to clinical examination. Even if financing were immediately available to build or expand a cancer control system, reaching capacity will take many years.